Follow The Filings

PROK ProKidney

ProKidney earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by PROK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PROK insider trades
  • None no insider bought on the open market
  • $3M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Brian Jg Pereira Director
    Sale
    $1.1M 757,164 shares at $1.41
    Traded Aug 18–20 Filed Aug 20
    ↗
  2. Brian Jg Pereira Director
    Sale
    $1.9M 757,162 shares at $2.49 100% of stake
    Traded Nov 12–13 Filed Nov 14, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 4 conversions.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 1.01,1.02,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.